Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent studies have suggested an association between hyperuricemia and adverse renal outcomes in nondiabetic populations. Data on the relationship between hyperuricemia and the risk of incident chronic kidney disease (CKD) in type 2 diabetic patients with normal or near-normal kidney function are lacking. We determined whether baseline serum uric acid levels predict the subsequent development of CKD in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We followed 1,449 type 2 diabetic patients with normal kidney function and without overt proteinuria for 5 years for the occurrence of incident CKD (defined as overt proteinuria or estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2). RESULTS: During a 5-year follow-up period, 194 (13.4%) patients developed incident CKD. The cumulative incidence of CKD was significantly greater in patients with hyperuricemia than in those without hyperuricemia (29.5 vs. 11.4%, P < 0.001). In univariate logistic regression analysis, the presence of hyperuricemia roughly doubled the risk of developing CKD (odds ratio [OR] 2.55 [95% CI 1.71–3.85], P < 0.001). After adjusting for age, sex, BMI, smoking status, diabetes duration, systolic blood pressure, antihypertensive treatment, insulin therapy, HbA1c, eGFR, and albuminuria, hyperuricemia was associated with an increased risk of incident CKD (adjusted OR 2.10 [1.16–3.76], P < 0.01). In continuous analyses, a 1-SD increment in the serum uric acid level was significantly associated with a 21% increased risk of CKD. CONCLUSIONS: In type 2 diabetic individuals with preserved kidney function, hyperuricemia seems to be an independent risk factor for the development of incident CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperuricemia may induce kidney inflammation and has been reported to be a risk factor for incident DKD in T2DM (43).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [43]
In the citing paper
“Hyperuricemia has been associated with kidney inflammation, and various observational studies documented a strong linear association between higher plasma uric acid levels and progressive kidney function loss (Zoppini et al., 2012).”
From A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors (2021) · cites this paper as Zoppini et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 1×
“Nonetheless, current GFR estimates facilitate the detection, evaluation, and management of CKD, and many organizations recommend the use of prediction equations for the evaluation of kidney function in large epidemiologic studies and in clinical practice (1,10,25,26).”
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Research works printed but not linked: 1
- Brenner, 2004, Diabetic nephropathy, 1777
Cited by
Items 101–200 of 295
Drapkina, O. M., Vi, M., Ai, M., Nasonov, E. L., Saiganov, S. A., Lila, A. M., Bashkinov, R. A., Bobkova, I. N., Baimukhamedov, C., Гайдукова, И. З., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3737 · Cited by 29
Sheikhbahaei, S., Fotouhi, A., Hafezi‐Nejad, N., Nakhjavani, M., & Esteghamati, A. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0119 · Cited by 29
“36 Recently, a 5-year observational study 17 showed that each 1 SD increment in the SUA level was associated with a 21% increase in incidence of CKD in patients with diabetes.”
InfluentialDiabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities
Aboolian, A., Urner, S., Roden, M., Jha, J. C., & Jandeleit-Dahm, K. A. M. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_576 · Cited by 28
Li, C., Wang, G., Zhang, J., Jiang, W., Wei, S., Wang, W., Pang, S., Pan, C., & Sun, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-69034-x · Cited by 28
“…we found that diabetic patients with high SUA levels were at increased risk of developing DKD, suggesting that increased SUA concentrations are a risk factor for the development and progression of diabetic nephropathy, which is consistent with the results of previous prospective studies 53,54 .”
ResultHanai, K., Tauchi, E., Nishiwaki, Y., Mori, T., Yokoyama, Y., Uchigata, Y., & Babazono, T. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy138 · Cited by 26
SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review
Kansara, A., Mubeen, F., & Shakil, J. (2022) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1120 · Cited by 25
Uric Acid: The Unknown Uremic Toxin
Treviño–Becerra, A. (2018) · Contributions to nephrology · doi:10.1159/000484275 · Cited by 25
Inflammasomes in the urinary tract: a disease-based review
Purves, J. T., & Hughes, F. M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00607.2015 · Cited by 25
Hu, Y., Liu, J., Li, H., Zhu, H. J., Liu, L., Yuan, Y., Chen, J., Wang, Y., Hu, X., & Xu, Y. (2018) · PeerJ · doi:10.7717/peerj.4515 · Cited by 24
Guo, J., Liu, C., Wang, Y., Shao, B., Fong, T. L., Lau, N. C., Zhang, H., Li, H.-D., Wang, J., Lu, X., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102482 · Cited by 24
Detrimental role of hyperuricemia on the cardio-reno-vascular system
Stack, A. G., Manolis, A. J., & Ritz, E. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1087984 · Cited by 24
Li, L., Wang, A., Zhang, R., Li, T., Wang, J., Bao, Y., & Jia, W. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0199-y · Cited by 24
de Oliveira, A. A. F., de Oliveira, T. F., Bobadilla, L. L., Garcia, C. C. M., Berra, C. M., de Souza-Pinto, N. C., de Medeiros, M. H. G., Mascio, P. D., Zatz, R., & Loureiro, A. P. D. M. (2017) · Scientific Reports · doi:10.1038/srep40544 · Cited by 23
Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle
Ceccarelli, D. C., Paleari, R., Solerte, B., & Mosca, A. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.009 · Cited by 22
Uric acid and diabetes mellitus: an update
Sk, S., Singh, R., Singh, S. K., Iquebal, M. A., Jaiswal, S., & Pradeep, K. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad081 · Cited by 22
Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
Gul, A., & Zager, P. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0985-5 · Cited by 22
Heras, M., García-Cosmes, P., Fernández‐Reyes, M. J., & Sánchez, R. (2013) · PubMed · doi:10.3265/nefrologia.pre2013.jan.11806 · Cited by 21
Chunlei, Y., Gu, L., Tao, W., & Changying, X. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.013 · Cited by 21
Ruzafa, J. C., Paczkowski, R., Boye, K. S., Tanna, G. L. D., Sheetz, M. J., Donaldson, R., Breyer, M. D., Neasham, D., & Voelker, J. R. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12640 · Cited by 21
Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile
Sunjaya, A. P., & Sunjaya, A. F. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.039 · Cited by 20
Sarıtemur, M., Türkeli, M., Kalkan, K., Tanboğa, İ. H., & Aksakal, E. (2013) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2013.10.011 · Cited by 20
Scheven, L., Joosten, M. M., de Jong, P. E., Bakker, S. J. L., Gansevoort, R. T., & For the PREVEND study group (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000613 · Cited by 20
“In this respect only a few studies have investigated the predictive role of both variables entered simultaneously into a multivariable model, but these studies did not investigate cardiovascular outcome.(29,38) We found that both variables were significantly associated with risk for cardiovascular outcome, independent…”
ResultCrystal clear – part I: The role of uric acid in cardiorenal disease
Borghi, C., Fogacci, F., & Cicero, A. F. G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.028 · Cited by 19
Serum uric acid and cardio-renal diseases
Ruilope, L. M., & Pontremoli, R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.790803 · Cited by 19
Uric acid, chronic kidney disease and type 2 diabetes: A cluster of vascular risk factors
Athyros, V. G., & Mikhailidis, D. P. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.012 · Cited by 19
Shi, R., Niu, Z., Wu, B., & Hu, F. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s255042 · Cited by 18
“In T2DM patients with preserved renal function, hyperuricaemia is an independent risk factor for chronic kidney disease (CKD).(26) Therefore, it is necessary to control and prevent the occurrence of HUA at an early stage for patients with T2DM.”
BackgroundEphraim, R. K. D., Awuku, Y. A., Numekevor, P., Botchway, F. A., Adoba, P., Dadzie, E. K., Abrefa, C. A., & Abaka‐Yawson, A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00746-x · Cited by 18
Chen, S. C.-J., Chang, J., Yeh, S.-M., Su, H., & Chen, H.-C. (2012) · American Journal of Hypertension · doi:10.1093/ajh/hps020 · Cited by 18
Xue, J., Li, B., Wang, J., Yu, S., Wang, A., An, P., & Mu, Y. (2020) · BioMed Research International · doi:10.1155/2020/3496328 · Cited by 17
“Notably, previous studies failed to adjust serum uric acid, a wellestablished confounding factor between obesity and CKD [9, 24, 25].”
BackgroundCorrelation between plasma renalase level and coronary artery disease
He, B., Hao, J., Sheng, W., Xiang, Y., Zhang, J., Zhu, H., Tian, J., Zhu, X., & Feng, Y. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.305.5286 · Cited by 17
“(2) Type 2 diabetic mellitus (T2DM): T2DM or history of T2DM was confirmed according to the Diagnostic Criteria for Diabetes issued by WHO in 1999.”
BackgroundMethodInfluentialThe effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia.
Jalalzadeh, M., Nurcheshmeh, Z., Mohammadi, R., Mousavinasab, N., & Ghadiani, M. H. (2012) · PubMed Central · Cited by 17
Factores de riesgo de nefropatía diabética
Pacheco, A. V. (2022) · ACTA MEDICA PERUANA · doi:10.35663/amp.2021.384.2256 · Cited by 16
Serum uric acid is associated with chronic kidney disease in elderly Chinese patients with diabetes
Zhou, Q., Ke, S., Yan, Y., Guo, Y., & Liu, Q. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2238825 · Cited by 16
“An observational longitudinal study demonstrated that hyperuricemia seemed to be an independent risk factor for the development of incident CKD in patients with diabetes [8].”
BackgroundResultKuwata, H., Okamura, S., Hayashino, Y., Ishii, H., & Tsujii, S. (2016) · Diabetology International · doi:10.1007/s13340-016-0254-2 · Cited by 16
Lai, Y., Chen, Y., Ku, P., Chen, L., & Yen, Y. (2021) · Medicine · doi:10.1097/md.0000000000027496 · Cited by 16
Borah, A. K., Ahmed, S. A., & Borah, J. C. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100225 · Cited by 15
Yamaguchi, A., Harada, M., Yamada, Y., Hashimoto, K., & Kamijo, Y. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0572-z · Cited by 15
“reported that hyperuricemia is an independent risk factor for CKD progression in patients with type 2 diabetes [2].”
BackgroundSalusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome
Aydın, S., & Aydin, S. (2013) · Biotechnic & Histochemistry · doi:10.3109/10520295.2013.821167 · Cited by 15
“In support of this, previous studies have shown a positive and independent association between serum uric acid levels (Sahin et al. 2013) and the risk of developing type 2 diabetes (Zoppini et al. 2012, Wang et al. 2012).”
ResultAsymptomatic Hyperuricemia and Risk Of Cardiovascular and Renal Diseases
Kobalava, Z. D., & Троицкая, Е. А. (2020) · Kardiologiia · doi:10.18087/cardio.2020.10.n1153 · Cited by 14
Osonoi, T., Saito, M., Hosoya, M., Douguchi, S., Ofuchi, K., & Katoh, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1042061 · Cited by 14
“In particular, type 2 diabetes is often complicated by hyperuricemia, and patients with these diseases have a significantly increased risk of developing CKD compared with those without hyperuricemia (5).”
BackgroundWang, L., Cheng, J.-F., Sun, L.-P., Song, Y.-X., Guo, L., Xu, J.-M., Wu, T., Mohan, C., Peng, A., Xu, H., et al. (2015) · BioMed Research International · doi:10.1155/2015/732317 · Cited by 14
“found that hyperuricemia was an independent risk factor for the development of incident CKD in type 2 diabetic patients [5].”
BackgroundChen, M.-Y., Wang, A.-P., Wang, J., Ke, J.-F., Yu, T.-P., Li, L., & Jia, W. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.03.001 · Cited by 14
Zhang, Y., Jiang, T., Liu, C., Hu, H., Dai, F., Li, X., & Zhang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.766778 · Cited by 14
“5 mg/dl) in women or if they were treated with allopurinol for lowering the level of uric acid (21).”
BackgroundZou, Y., Zhao, L., Zhang, J., Wang, Y., Wu, Y., Ren, H., Wang, T., Zhang, R., Wang, J., Zhao, Y., et al. (2021) · Endocrine Connections · doi:10.1530/ec-21-0307 · Cited by 13
“The means of SUA were 3.6, 4.9, 5.8 and 7.3 mg/dL for the quartile 1 to quartiles 4, respectively.”
InfluentialChen, Z. (2014) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1909w · Cited by 13
“We found that serum uric acid is negatively associated with eGFR in the reduced renal function stage ( 60 mL/min/1.73 m2) and is an independent risk factor for CKD in individuals with T2DM and stable CAD.”
BackgroundResultInfluentialLiu, L., Gao, B., Wang, J., Yang, C., Wu, S., Wu, Y., Chen, S., Li, Q., Zhang, H., Wang, G., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12983 · Cited by 13
“Because over half of diabetic patients with microalbuminuria could achieve remission or regression,(12) we used macroalbuminuria to define incident DKD, which is similar to previous studies.(13)”
ResultLiu, P., Liang, Y., Cui, S., Hu, K., Liu, L., Shao, X., & Lei, M. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071771 · Cited by 12
Wu, S., Wang, H., Pan, D., Guo, J., Zhang, F., Ning, Y., Gu, Y., & Guo, L. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04094-6 · Cited by 12
“Zoppini et al. [24] investigated the incidence rate of new CKD in 1449 T2D patients.”
BackgroundWu, H., Li, Y., Ren, L., Li, J., Wang, Y., Jiang, C., & Wu, J. (2023) · BMC Public Health · doi:10.1186/s12889-023-16455-4 · Cited by 12
“However, the link between some laboratory test variables and CKD is controversial, such as albumin (Alb) [11, 12] and uric acid (UA) [13–15].”
BackgroundResultTo Study Serum Uric Acid and Urine Microalbumin in Type-2 Diabetes Mellitus
(2015) · International Journal of Medical Science · doi:10.14445/23939117/ijms-v2i3p104 · Cited by 12
Park, D.-J., Choi, S., Xu, H., Kang, J., Lee, J. S., Choi, Y. D., & Lee, S. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/k4rdi7 · Cited by 12
Le, H. T., Le, T. T., Tran, N. M. T., Nguyen, T. T. T., Minh, N. C. S., Le, Q. T., Tram, T. A. T., Tran, T. D., Doan, T. X., Duong, M. H. T., et al. (2021) · Healthcare · doi:10.3390/healthcare9101341 · Cited by 12
Guo, M., Niu, J., Li, S., Ye, X., Fang, H., Zhao, Y.-P., & Gu, Y. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.016 · Cited by 12
Kodithuwakku, N. D., Feng, Y., Zhang, Y.-Y., Pan, M., Fang, W., & Li, Y. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.013 · Cited by 12
“Several prospective studies have reported that hyperuricemia is accompanied with chronic kidney disease including glomerular hypertrophy and endothelial dysfunction (Zoppini et al., 2012).”
BackgroundUric Acid and Impairment of Renal Function in Non-diabetic Hypertensive Patients
Hung, Y., Huang, C., Lin, L., & Chen, J.-W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.746886 · Cited by 11
Ling, Y., Li, X., & Gao, X. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131485 · Cited by 11
“It also has been shown that hyperuricemia is an independent risk factor for the development of incident CKD in type 2 diabetic patients with preserved kidney function.(34)”
BackgroundAssociation of serum uric acid with nephropathy in Iranian type 2 diabetic patients
Razi, F., Nasli‐Esfahani, E., & Bandarian, F. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0340-z · Cited by 11
“In a 5-year followup of Italian patients with DM type 2, hyperuricaemia was recognized as an independent risk factor for the development of DN [19].”
BackgroundYan, W., Wen, S., & Zhou, L. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s429068 · Cited by 10
“In continuous analyses, each 1-SD increase in serum uric acid level was significantly associated with a 21% increase in CKD risk.(14) It is speculated that hyperuricemia is an independent risk factor for diabetic kidney disease in type 2 diabetic patients with normal renal function.”
BackgroundYan, D., Wang, J., Jiang, F., Zhang, R., Sun, X., Wang, T., Wang, S., Peng, D., He, Z., Bao, Y., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.018 · Cited by 10
Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia
Ueno, N. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3219w · Cited by 10
“High levels of serum uric acid are risk factors for the progression of renal disease [7] and an independent predictor of new-onset CKD development [8].”
BackgroundGurung, R. L., Yiamunaa, M., Liu, J., Dorajoo, R., Wang, J., Wang, L., Liu, S., Chan, C., Ang, K., Shao, Y. M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac192 · Cited by 10
Joo, H. J., Jeong, H. S., Kook, H., Lee, S. H., Park, J. H., Hong, S. J., Yu, C. W., & Lim, D.-S. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0840-2 · Cited by 10
“Therefore, hyperuricemia is associated with other cardiovascular risk factors such as hypertension, diabetes mellitus, and chronic kidney disease [19, 20].”
BackgroundLi, Y., Fan, X., Li, C., Zhi, X., Peng, L., Han, H., & Sun, B. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0266 · Cited by 9
“[7] suggests that serum UA independently associated with microalbuminuria in diabetic patients and, is also an independent risk factor for diabetic nephropathy [8, 9].”
BackgroundÁcido úrico como factor de riesgo cardiovascular
Cebollada, J., & Gimeno-Orna, J. A. (2012) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2012.04.001 · Cited by 9
Zeng, C., Cheng, D., Sheng, X., Jian, G., Fan, Y., Chen, Y., Li, J., Bao, H., & Wang, N. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5016093 · Cited by 9
Li, X., Cheng, L., Jiang, T., Liu, C., Zhang, S., Hu, H., Dai, F., Zhang, Q., & Lu, Y. (2021) · Journal of International Medical Research · doi:10.1177/03000605211051225 · Cited by 8
“5mg/dL) in women or the use of allopurinol to lower the circulating UA concentration.(13) “Older” patients were defined as being >65 years old.”
BackgroundLi, X., Xuejun, X., Xiaojuan, S., Yu, H., & Mingchao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1160615 · Cited by 8
Plasma uric acid and renal haemodynamics in type 2 diabetes patients
Suijk, D. L. S., Smits, M. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Joles, J. A., & van Raalte, D. H. (2019) · Nephrology · doi:10.1111/nep.13645 · Cited by 8
“range) represents an independent risk factor for adverse renal outcomes in the general population(4) and in T2D patients.(5)”
BackgroundAdverse Effects of Khat (Catha edulis) Chewing in Yemeni Adults: A Case-Control Study
Ahmed, K. A., Abdoh, T. H., Farah, H. S., Al‐Qaisi, T. S., Qaisi, K. M. A., & Alhmoud, J. F. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i3.3010 · Cited by 7
Sun, M., Liu, Q., Liu, Y., Ning, N., Zhou, J., Zhou, D., Zheng, H., Wu, S., Gao, J., & Ma, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16184 · Cited by 7
“27”
Wu, H., Li, X., Zhang, W., Peng, H., & Jiang, H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01377-x · Cited by 7
“%) than in those without hyperuricemia (11.4%, p = 0.001) after 5 years of follow-up [16].”
BackgroundInfluentialAl-Hajji, A., Alsubaie, H. A., Albaqshi, H. T., Al-Hajji, H., AlEssa, F. A., & Ali, B. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_244_20 · Cited by 7
Serum albumin predicts hyperuricemia in patients with idiopathic membranous nephropathy
Wei, C., Li, T., Xuan, X., Hu, H., Xiao, X., & Li, J. (2021) · Clinical Nephrology · doi:10.5414/cn110524 · Cited by 7
Non-Immunologic Causes of Late Death-Censored Kidney Graft Failure: A Personalized Approach
Ponticelli, C., & Citterio, F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081271 · Cited by 7
Deng, L., Zhong, G., Peng, Y., & Zhu, Z. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12664 · Cited by 7
The problem of cardio-renal diseases in patients with gout
Ferri, C. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1378518 · Cited by 7
Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel
Solomon, D. H., Weissman, J. S., Choi, H. K., Atlas, S. J., Berardinelli, C., Dedier, J. J., Fischer, M. A., FitzGerald, J. D., Hinteregger, E., Johnsen, B., et al. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11243 · Cited by 7
Gout, hyperuricemia and chronic kidney disease: New treatment possibilities
Kochman, P., & Stompór, T. P. (2016) · Polish Annals of Medicine · doi:10.1016/j.poamed.2016.04.001 · Cited by 7
Fructose tolerance test in obese people with and without type 2 diabetes
Al‐Ozairi, E., Rivard, C. J., Sánchez‐Lozada, L. G., Lanaspa, M. A., Bjornstad, P., Salem, D. A., Alhubail, A., Megahed, A., Kuwabara, M., Johnson, R. J., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12984 · Cited by 6
Zhang, B., & Dong, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297873 · Cited by 6
Urate Reduction and Renal Preservation: What Is the Evidence?
Macías, N., Goicoechea, M., de Vinuesa, M. S. G., Verdalles, Ú., & Luño, J. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0386-3 · Cited by 6
Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
Rob, D., Marek, J. J., Dostálová, G., Goláň, L., & Linhart, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166290 · Cited by 6
Feng, X., Zheng, Y., Guan, H., Zhou, X. C., Xu, Y., Zhang, X., Fu, C., Xiao, J., & Ye, Z. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1850760 · Cited by 6
Drapkina, O. M., Vi, M., Ai, M., Nasonov, E. L., Saiganov, S. A., Lila, A. M., Bashkinov, R. A., Bobkova, I. N., Baimukhamedov, C., Gaydukova, I. Z., et al. (2025) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov676852 · Cited by 5
Fan, J., Zuo, L., Li, F., Wang, B., An, Y., & Yu, D. (2024) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2024.04.002 · Cited by 5
Chen, S., Wang, P., Ji, G., Jiang, Q., Hong, X., Ma, W., Huang, R., Chen, Z., & Peng, J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.647287 · Cited by 5
Park, G., Choi, B., Kang, S., Kim, B., & Chang, M. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185259 · Cited by 5
“Additionally, we used the linear mixed model to analyze gradual changes in repeatedly measured eGFR values (calculated by the CKD-EPI equation) for the SGLT2 inhibitors group and DPP-4 inhibitors group.”
BackgroundInfluentialChang, M., Cheng, J., Chen, W., Hsu, C., Chen, K., Chen, Y., & Chien, R. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.01.010 · Cited by 5
Yang, Y., Yang, B., Wang, B., Zhou, H., Yang, M., & Liu, B. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.355 · Cited by 5
Shakour, N., Mahdinezhad, M. R., Hadjzadeh, M., Sahebkar, A., & Hadizadeh, F. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10272-8 · Cited by 5
“…markers before and after treatment not only reveals insights into the metabolic changes associated with T2DM but also serves as a vital indicator of how well the treatment is working (Bazyar et al. 2023; Bungau et al. 2023; Gilani et al. 2021; Zoppini et al. 2012; Bin Dayel et al. 2024).”
Arévalo‐Lorido, J. C., Carretero‐Gómez, J., & Robles, N. R. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1750395 · Cited by 5
“independent risk factor for the progression of renal dysfunction [8], and CKD leads to an increased risk of”
BackgroundWeisman, A., TOMLINSON, G. A., Lipscombe, L. L., Garg, A. X., Perkins, B. A., Cherney, D. Z. I., & HAWKER, G. A. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.005 · Cited by 5
Uric Acid Control in Advanced Chronic Kidney Disease in a Southeastern US Urban Cohort
Fülöp, T., Koch, C. A., Norris, L. T., Rodríguez, B., Szarvas, T., Lengvárszky, Z., Csongrádi, É., & Dixit, M. P. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000862 · Cited by 5
Shen, K., Huang, Y., Zhang, J., Chen, L., Cai, X., Pan, J., Li, J., Li, L., & Chen, L. (2024) · Medicine · doi:10.1097/md.0000000000040544 · Cited by 4
“[10,32,33] In addition, higher insulin levels further reduce uric acid excretion in the kidneys.”
Osonoi, T., Shirabe, S., Saito, M., Hosoya, M., Watahiki, N., Douguchi, S., Ofuchi, K., & Katoh, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1655502 · Cited by 4
Qian, F., Hong, Z., Wei, J., Shen, H., Lin, S., Geng, M., Deng, J., & Wu, S. (2025) · European journal of medical research · doi:10.1186/s40001-025-03465-8 · Cited by 4
“…that elevated serum uric acid was an independent risk factor for proteinuria, with a moderate effect size, consistent with findings in other East Asian populations [11]. m 2 ), hyperuricemia (serum uric acid > 7 mg/dL in men or > 6 mg/dL in women) was significantly associated with CKD [12].”
Alex, R., Press, E., Sanchez, L. M., Whitson, J. D., Marder, B. A., & Tumlin, J. A. (2024) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000002068 · Cited by 4
Canagliflozin: A Comprehensive Review of Advances in Preclinical Research
Imran, B., Ahsan, F., Mahmood, T., Khan, M. M. U., Bano, S., Zaidi, S. M. H., Ansari, J. A., & Singh, A. (2025) · Drug Research · doi:10.1055/a-2577-1899 · Cited by 4
Hiperuricemia, gota y enfermedad renal crónica
Goicoechea, M., de Vinuesa, S. G., Arroyo, D., & Luño, J. (2012) · Cited by 4
Sengsuk, J., Tangvarasittichai, O., & Tangvarasittichai, S. (2018) · Madridge Journal of Diabetes · doi:10.18689/mjd-1000107 · Cited by 4
“[20, 21] In general physiological, renal clearance of SUA is often impaired during kidney injury or dysfunction, renal function is the major confounder in studies of the association between SUA with CKD progression [22].”
BackgroundMethod
Metadata
- Authors
- Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E.
- Affiliations
- University of Verona (IT)
- Division of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado
- Corresponding author
- Targher, Giovanni
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-12-09
- Volume
- 35
- Issue
- 1
- Pages
- 99-104
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3241303
- OpenAlex
- W2151157525
- Cited by
- 274
- References
- 35
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 21 · 2021: 27 · 2020: 19 · 2019: 24 · 2018: 24 · 2017: 19 · 2016: 14 · 2015: 24 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- serum uric acid, hyperuricemia, chronic kidney disease, type 2 diabetes, preserved renal function, incident CKD risk, estimated glomerular filtration rate, albuminuria, proteinuria, risk factors
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Italy, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Uric Acid, Hyperuricemia, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
